The alimentary tract and metabolism medicine sales in Portugal have demonstrated a significant upward trend from 2013 to 2023, growing from 396.1 million Euros to 825.6 million Euros. This is an overall increase of more than double in ten years. Notably, the growth has particularly accelerated from 2018 onwards, averaging 9.98% annually over the past five years. The year-on-year variations peaked at 13.51% in 2022, showing a consistent and strong expansion phase.
Future trends indicate continued robust growth with forecasted annual increases, leading to a projected value of 1090 million Euros by 2028. The expected CAGR over the next five years is estimated at 4.07%, offering a cumulative growth rate of 22.07% by 2028. Key aspects to watch include the impact of emerging therapies, regulatory policies, and demographic changes particularly as they relate to an aging population and the rising prevalence of chronic conditions.
